Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Biologic therapies for dyslipidemia.
Immunologic changes after nasal provocation with allergen.
Role of STAT6 signaling in the induction and long-term maintenance of tolerance mediated by CTLA4-Ig.
Visual and quantitative ictal EEG predictors of outcome after temporal lobectomy.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Biologic therapies for dyslipidemia.
Biologic therapies for dyslipidemia. Curr Atheroscler Rep. 2004 Jan; 6(1):69-72.
View in:
PubMed
subject areas
Apolipoprotein A-I
Autoimmunity
Carrier Proteins
Cholesterol Ester Transfer Proteins
Clinical Trials as Topic
Genetic Therapy
Glycoproteins
Humans
Hyperlipidemias
Hypolipidemic Agents
authors with profiles
Michael H. Davidson